Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-26

Clinical Trial Update: Deficit Hyperactivity Disorder / Substance Use Disorder Comorbidity in Integrated Treatment [NA]

View source ↗

Summary

This is a clinical trial in Paris evaluating integrated treatment for comorbid ADHD and substance use disorder; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Attention Deficit Hyperactivity Disorder (ADHD), Substance-related Disorder | NA | Status: RECRUITING